147 related articles for article (PubMed ID: 38731842)
1. Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines.
Albani M; Fassi EMA; Moretti RM; Garofalo M; Montagnani Marelli M; Roda G; Sgrignani J; Cavalli A; Grazioso G
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731842
[TBL] [Abstract][Full Text] [Related]
2. Focused Design of Novel Cyclic Peptides Endowed with GABARAP-Inhibiting Activity.
Fassi EMA; Garofalo M; Sgrignani J; Dei Cas M; Mori M; Roda G; Cavalli A; Grazioso G
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563459
[TBL] [Abstract][Full Text] [Related]
3. A novel conformation of the LC3-interacting region motif revealed by the structure of a complex between LC3B and RavZ.
Kwon DH; Kim L; Kim BW; Kim JH; Roh KH; Choi EJ; Song HK
Biochem Biophys Res Commun; 2017 Aug; 490(3):1093-1099. PubMed ID: 28668392
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of pyridinium-hydrazone derivatives as potential antitumoral agents.
Parlar S; Erzurumlu Y; Ilhan R; Ballar Kırmızıbayrak P; Alptüzün V; Erciyas E
Chem Biol Drug Des; 2018 Jul; 92(1):1198-1205. PubMed ID: 29415336
[TBL] [Abstract][Full Text] [Related]
5. Malformin A1 promotes cell death through induction of apoptosis, necrosis and autophagy in prostate cancer cells.
Liu Y; Wang M; Wang D; Li X; Wang W; Lou H; Yuan H
Cancer Chemother Pharmacol; 2016 Jan; 77(1):63-75. PubMed ID: 26645406
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer.
Quan Y; Lei H; Wahafu W; Liu Y; Ping H; Zhang X
Biomed Pharmacother; 2019 Dec; 120():109490. PubMed ID: 31574376
[TBL] [Abstract][Full Text] [Related]
7. FYCO1 Contains a C-terminally Extended, LC3A/B-preferring LC3-interacting Region (LIR) Motif Required for Efficient Maturation of Autophagosomes during Basal Autophagy.
Olsvik HL; Lamark T; Takagi K; Larsen KB; Evjen G; Øvervatn A; Mizushima T; Johansen T
J Biol Chem; 2015 Dec; 290(49):29361-74. PubMed ID: 26468287
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Biological Evaluation of a Structurally Simplified Syringolin A Analogues.
Chiba T; Kitahata S; Matsuda A; Ichikawa S
Chem Pharm Bull (Tokyo); 2016; 64(7):811-6. PubMed ID: 27373636
[TBL] [Abstract][Full Text] [Related]
10. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Marine Cyclopeptide Galaxamide Analogues as Potential Anticancer Agents.
Li D; Liao X; Zhong S; Zhao B; Xu S
Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323457
[TBL] [Abstract][Full Text] [Related]
12. Time-resolved FRET and NMR analyses reveal selective binding of peptides containing the LC3-interacting region to ATG8 family proteins.
Atkinson JM; Ye Y; Gebru MT; Liu Q; Zhou S; Young MM; Takahashi Y; Lin Q; Tian F; Wang HG
J Biol Chem; 2019 Sep; 294(38):14033-14042. PubMed ID: 31362979
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Biological Activity of Isosyringolin A.
Kitahata S; Chiba T; Yoshida T; Ri M; Iida S; Matsuda A; Ichikawa S
Org Lett; 2016 May; 18(9):2312-5. PubMed ID: 27123978
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
15. Stapled Peptide Inhibitors of Autophagy Adapter LC3B.
Cerulli RA; Shehaj L; Brown H; Pace J; Mei Y; Kritzer JA
Chembiochem; 2020 Oct; 21(19):2777-2785. PubMed ID: 32406996
[TBL] [Abstract][Full Text] [Related]
16. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B
Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
18. GABARAPs and LC3s have opposite roles in regulating ULK1 for autophagy induction.
Grunwald DS; Otto NM; Park JM; Song D; Kim DH
Autophagy; 2020 Apr; 16(4):600-614. PubMed ID: 31208283
[TBL] [Abstract][Full Text] [Related]
19. The role of Runx2 in facilitating autophagy in metastatic breast cancer cells.
Tandon M; Othman AH; Ashok V; Stein GS; Pratap J
J Cell Physiol; 2018 Jan; 233(1):559-571. PubMed ID: 28345763
[TBL] [Abstract][Full Text] [Related]
20. RA-XII, a bicyclic hexapeptidic glucoside isolated from Rubia yunnanensis Diels, exerts antitumor activity by inhibiting protective autophagy and activating Akt-mTOR pathway in colorectal cancer cells.
Wang J; Wang J; Li L; Feng L; Wang YR; Wang Z; Tan NH
J Ethnopharmacol; 2021 Feb; 266():113438. PubMed ID: 33017635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
